Capricor Therapeutics CAPR
NASDAQ CAPR
$6.18 +0.30 (+5.10%)
As of: Oct 22, 2026 · 1:00 PM EDT

Capricor Therapeutics (CAPR) Interest Paid (2015 - 2016)

Updated

Analysis

Capricor Therapeutics (CAPR) Interest Paid (2015 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,171.37 Bn 1,139.96 Bn 19.71 Bn -
2 Johnson & Johnson 645.23 Bn 565.09 Bn 17.30 Bn -
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn -
4 Merck 361.34 Bn 315.71 Bn 12.21 Bn -
5 Novartis Ag 302.82 Bn 266.81 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 267.91 Bn 241.60 Bn 12.86 Bn 1.07 Bn
7 Amgen 242.39 Bn 197.79 Bn 7.24 Bn -
8 Gilead Sciences 193.55 Bn 167.74 Bn 6.22 Bn -
9 Pfizer 172.05 Bn 118.70 Bn 10.94 Bn 1.25 Bn
10 Capricor Therapeutics 358.56 Mn -574.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 1,343.00
Jun 30, 2015 2,685.00
API Access

Capricor Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=CAPR&period=max&api_key=YOUR_API_KEY